ApprovalTrail

Approval · Notice of Compliance 12610 · 2011

DURELA: Notice of Compliance 12610

Issued August 30, 2011

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number
12610
Date
August 30, 2011
Company
Cipher Pharmaceuticals Inc.Mississauga, Ontario, Canada
Product type
Prescription Pharmaceutical
Submission
New Drug Submission (NDS)
Submission class
Other
Therapeutic class
Opioid Analgesic

Products in this notice

BrandDINStatus today
DURELA02373017Marketed
DURELA02373025Marketed
DURELA02373033Marketed

Medicinal ingredients